Disetronic, Type 2 Diabetes In MiniMed's Sights Following Medtronic Merger

Medtronic's international marketing infrastructure provides a platform for MiniMed to expand its presence in the overseas diabetes care market and an opportunity to challenge the dominance of Disetronic in Europe. Medtronic agreed to acquire MiniMed for $3.28 bil. on May 30.